Chiara Carcieri
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
- Antifungal resistance and susceptibility
Papers in
-
- HIV/AIDS drug development and treatment 5
- Antifungal resistance and susceptibility 4
-
- Hepatitis C virus research 5
- Co-authors
- Antonio D’Avolio (20 shared papers)Giovanni Di Perri (19 shared papers)Amedeo De Nicolò (18 shared papers)Jessica Cusato (16 shared papers)F. Favata (11 shared papers)Marco Simiele (4 shared papers)Alessandra Ariaudo (10 shared papers)Lucio Boglione (11 shared papers)
- Journals
- Pharmacogenomics (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)British Journal of Clinical Pharmacology (1 paper)Biomedicines (1 paper)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Chiara Carcieri
20 papers receiving 450 citations
Peers
Comparison fields: 5 of 72
- Hepatology 109
- Infectious Diseases 191
- Pharmacology 101
- Virology 24
- Toxicology 17
Countries citing papers authored by Chiara Carcieri
This map shows the geographic impact of Chiara Carcieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Carcieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Carcieri more than expected).
Fields of papers citing papers by Chiara Carcieri
This network shows the impact of papers produced by Chiara Carcieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Carcieri. The network helps show where Chiara Carcieri may publish in the future.
Co-authors
The 24 scholars most cited alongside Chiara Carcieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 112 | |
| 2 | 2017 | 57 | |
| 3 | 2017 | 49 | |
| 4 | 2017 | 43 | |
| 5 | 2014 | 37 | |
| 6 | 2018 | 26 | |
| 7 | 2015 | 24 | |
| 8 | 2017 | 18 | |
| 9 | 2017 | 15 | |
| 10 | 2016 | 11 | |
| 11 | 2017 | 11 | |
| 12 | 2017 | 10 | |
| 13 | 2016 | 10 | |
| 14 | 2018 | 9 | |
| 15 | 2018 | 9 | |
| 16 | 2017 | 8 | |
| 17 | 2017 | 5 | |
| 18 | 2018 | 4 | |
| 19 | 2017 | 2 | |
| 20 | 2018 | 1 |
About Chiara Carcieri
Chiara Carcieri is a scholar working on Infectious Diseases, Hepatology, Pathology and Forensic Medicine, Epidemiology and Pharmacology, having authored 20 papers that have together received 461 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Hepatitis C virus research (5 papers), Antifungal resistance and susceptibility (4 papers), Vitamin D Research Studies (4 papers), Fungal Infections and Studies (3 papers), HIV Research and Treatment (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and HIV-related health complications and treatments (1 paper). The work is most often cited by research in Hepatology (109 citations), Infectious Diseases (191 citations), Pharmacology (101 citations), Virology (24 citations) and Toxicology (17 citations). Chiara Carcieri has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Antonio D’Avolio, Giovanni Di Perri, Amedeo De Nicolò, Jessica Cusato, F. Favata, Marco Simiele, Alessandra Ariaudo, Lucio Boglione, Chiara Simona Cardellino and Sarah Allegra. Their work appears in journals such as Pharmacogenomics, Journal of Antimicrobial Chemotherapy, Journal of Pharmaceutical and Biomedical Analysis, British Journal of Clinical Pharmacology and Biomedicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.